Decoy Therapeutics Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2026 | 1.02 K | $6.67 K | 100.00% | 0.21% |
| UBS GROUP AG | 05/05/2026 | 546 | $3.57 K | 100.00% | 0.11% |
| ADVISORY SERVICES NETWORK, LLC | 05/15/2026 | 41 | $268 | 100.00% | 0.01% |
| MORGAN STANLEY | 05/15/2026 | 1 | $7 | 100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Decoy Therapeutics Inc. institutional Ownership - FAQ's
During the previous two years, 4 institutional investors and hedge funds held shares of Decoy Therapeutics Inc.. The most heavily invested institutionals were:
Tower Research Capital LLC (TRC): 1,021
UBS Group AG: 546
Advisory Services Network, LLC: 41
MORGAN STANLEY: 1
0.33% of Decoy Therapeutics Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 1.61 K shares in the last 24 months. This purchase volume represents approximately $13.85 K in transactions.